Business Context and Reporting Period
This Form 8-K Current Report was filed by Conversion Labs, Inc. (not Lifemd, Inc.) on December 11, 2020, covering events occurring on December 8, 2020. The filing details unregistered equity sales to executive officers and the execution of an amended employment agreement.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on corporate governance and equity compensation events.
Material Changes and Equity Transactions
- Unregistered Equity Sales (Item 3.02): The Company issued an aggregate of 2,000,000 shares of Common Stock to CEO Justin Schreiber and CTO Stefan Galluppi. These "Milestone Shares" were issued because the Company's stock price met specific 90-day average trading price thresholds ($2.50 and $3.75) previously established in a 2019 agreement.
- Lock-Up Agreement: The newly issued Milestone Shares are subject to an 180-day lock-up agreement signed by the executives on November 3, 2020.
- Employment Agreement Amendment (Item 5.02): The Company entered into an Amended and Restated Employment Agreement with Chief Acquisition Officer Nicholas Alvarez.
Guidance, Outlook, and Compensation Details
The filing contains no forward-looking financial guidance or market outlook. However, it details specific compensation arrangements:
- Nicholas Alvarez Compensation:
- Base Salary: $172,400 per year.
- Stock Options: Granted options to purchase 200,000 shares, vesting monthly over 35 months (final vesting December 8, 2023).
- Restricted Stock Units (RSUs): Eligible for up to 300,000 RSUs contingent on Telemedicine Brands achieving specific revenue milestones. Vesting occurs upon a Change of Control or by December 8, 2023.
- Severance: In the event of termination without Good Cause or resignation for Good Reason, Alvarez is entitled to a lump-sum payment equal to six months of base salary plus a pro-rata bonus, along with continued benefits coverage for six months.
Investor Verification Checklist
- Verify the current trading price of Conversion Labs, Inc. stock to confirm the status of the $2.50 and $3.75 milestones mentioned in the 2019 agreement.
- Review the full text of the Amended and Restated Employment Agreement (Exhibit 10.1) to understand the specific revenue milestones required for Nicholas Alvarez's RSUs.
- Confirm the total outstanding share count to assess the dilution impact of the 2,000,000 shares issued to Schreiber and Galluppi.
- Note that the filing explicitly states the securities were not registered under the Securities Act of 1933 but claimed exemptions under Section 4(a)(2) and/or Regulation D.